Merck & Co., Inc. (MRK) Tops Q3 EPS by 5c; Narrows FY13 EPS Outlook
Tweet Send to a Friend
Merck & Co., Inc. (NYSE: MRK) reported Q3 EPS of $0.92, $0.05 better ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
